Neil H. Bander Department of Urology Weill Cornell Medical College Biography Publications Institution JoVE Articles Neil H. Bander has not added a biography. If you are Neil H. Bander and would like to personalize this page please email our Author Liaison for assistance. Publications A Prospective Pilot Study of (89)zr-j591/prostate Specific Membrane Antigen Positron Emission Tomography in Men with Localized Prostate Cancer Undergoing Radical Prostatectomy The Journal of Urology. May, 2014 | Pubmed ID: 24135437 Circulating Tumor Cells from Prostate Cancer Patients Interact with E-selectin Under Physiologic Blood Flow PloS One. 2013 | Pubmed ID: 24386459 Prostate-specific Membrane Antigen Expression in Tumor-associated Vasculature of Breast Cancers APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Dec, 2013 | Pubmed ID: 24304465 Bone Marrow Recovery and Subsequent Chemotherapy Following Radiolabeled Anti-prostate-specific Membrane Antigen Monoclonal Antibody J591 in Men with Metastatic Castration-resistant Prostate Cancer Frontiers in Oncology. 2013 | Pubmed ID: 23986881 Characterization of a Hybrid Dielectrophoresis and Immunocapture Microfluidic System for Cancer Cell Capture Electrophoresis. Nov, 2013 | Pubmed ID: 23925921 Antibody-drug Conjugate Target Selection: Critical Factors Methods in Molecular Biology (Clifton, N.J.). 2013 | Pubmed ID: 23913139 Enrichment of Prostate Cancer Cells from Blood Cells with a Hybrid Dielectrophoresis and Immunocapture Microfluidic System Biomedical Microdevices. Dec, 2013 | Pubmed ID: 23807279 Phase II Study of Lutetium-177-labeled Anti-prostate-specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-resistant Prostate Cancer Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2013 | Pubmed ID: 23714732 Synergistic Cytotoxicity of Irinotecan and Cisplatin in Dual-drug Targeted Polymeric Nanoparticles Nanomedicine (London, England). May, 2013 | Pubmed ID: 23075285 Androgen Receptor Signaling in Circulating Tumor Cells As a Marker of Hormonally Responsive Prostate Cancer Cancer Discovery. Nov, 2012 | Pubmed ID: 23093251 Antibody-drug Conjugate Technology Development for Hematologic Disorders Clinical Advances in Hematology & Oncology : H&O. Aug, 2012 | Pubmed ID: 23072775 Functional Characterization of Circulating Tumor Cells with a Prostate-cancer-specific Microfluidic Device PloS One. 2012 | Pubmed ID: 22558290 Preclinical Development and Clinical Translation of a PSMA-targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile Science Translational Medicine. Apr, 2012 | Pubmed ID: 22491949 High Expression of Prostate-specific Membrane Antigen in the Tumor-associated Neo-vasculature is Associated with Worse Prognosis in Squamous Cell Carcinoma of the Oral Cavity Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc. Aug, 2012 | Pubmed ID: 22460809 Immunocapture of Prostate Cancer Cells by Use of Anti-PSMA Antibodies in Microdevices Biomedical Microdevices. Apr, 2012 | Pubmed ID: 22143878 Prostate-specific Membrane Antigen As a Potential Novel Vascular Target for Treatment of Glioblastoma Multiforme Archives of Pathology & Laboratory Medicine. Nov, 2011 | Pubmed ID: 22032578 Targeting the Internal Epitope of Prostate-specific Membrane Antigen with 89Zr-7E11 Immuno-PET Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Oct, 2011 | Pubmed ID: 21908391 Taxane-induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer Cancer Research. Sep, 2011 | Pubmed ID: 21799031 Targeted, Activatable, in Vivo Fluorescence Imaging of Prostate-specific Membrane Antigen (PSMA) Positive Tumors Using the Quenched Humanized J591 Antibody-indocyanine Green (ICG) Conjugate Bioconjugate Chemistry. Aug, 2011 | Pubmed ID: 21740058 非侵襲計測陽電子放出放射性医薬品とそのターゲット膜前立腺特異抗原シグナリング アンドロゲン受容体の。 Proceedings of the National Academy of Sciences of the United States of America. Jun, 2011 | Pubmed ID: 21606347 89Zr-DFO-J591 for ImmunoPET of Prostate-specific Membrane Antigen Expression in Vivo Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Aug, 2010 | Pubmed ID: 20660376 Saporin Toxin-conjugated Monoclonal Antibody Targeting Prostate-specific Membrane Antigen Has Potent Anticancer Activity The Prostate. Sep, 2010 | Pubmed ID: 20623630 ChemoRadナノ粒子:同時化学放射線療法の標的化送達のための新しい多機能ナノ粒子のプラットフォーム Nanomedicine (London, England). Apr, 2010 | Pubmed ID: 20394530 Anti-prostate-specific Membrane Antigen-based Radioimmunotherapy for Prostate Cancer Cancer. Feb, 2010 | Pubmed ID: 20127956 Capture of Circulating Tumor Cells from Whole Blood of Prostate Cancer Patients Using Geometrically Enhanced Differential Immunocapture (GEDI) and a Prostate-specific Antibody Lab on a Chip. Jan, 2010 | Pubmed ID: 20024046 胃癌・大腸癌の前立腺特異膜抗原の発現、ナノスケールでは。 Human Pathology. Dec, 2009 | Pubmed ID: 19716160 Editorial Comment The Journal of Urology. Sep, 2009 | Pubmed ID: 19616227 Docetaxel Down-regulates the Expression of Androgen Receptor and Prostate-specific Antigen but Not Prostate-specific Membrane Antigen in Prostate Cancer Cell Lines: Implications for PSA Surrogacy The Prostate. Oct, 2009 | Pubmed ID: 19575420 複合前立腺がんのイメージングおよび治療のための超常磁性酸化鉄ナノ粒子アプタマーバイオコンジュゲート ChemMedChem. Sep, 2008 | Pubmed ID: 18613203 Interaction of Prostate Specific Membrane Antigen with Clathrin and the Adaptor Protein Complex-2 International Journal of Oncology. Nov, 2007 | Pubmed ID: 17912448 Active and Passive Immunotherapy: Vaccines and Antibodies BJU International. May, 2007 | Pubmed ID: 17441928 Vascular Targeted Therapy with Anti-prostate-specific Membrane Antigen Monoclonal Antibody J591 in Advanced Solid Tumors Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Feb, 2007 | Pubmed ID: 17290063 Clinical Utility of Radiolabeled Monoclonal Antibodies in Prostate Cancer Clinical Genitourinary Cancer. Mar, 2006 | Pubmed ID: 16729907 Technology Insight: Monoclonal Antibody Imaging of Prostate Cancer Nature Clinical Practice. Urology. Apr, 2006 | Pubmed ID: 16607370 Antibody-based Therapeutics: Focus on Prostate Cancer Cancer Metastasis Reviews. Dec, 2005 | Pubmed ID: 16408160 Radioimmunotherapy of Prostate Cancer Using 90Y- and 177Lu-labeled J591 Monoclonal Antibodies: Effect of Multiple Treatments on Myelotoxicity Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2005 | Pubmed ID: 16203821 糖鎖と微小管の整合性アピカル膜前立腺特異抗原のターゲット設定に関与している: 免疫療法のための含意。 Molecular Cancer Therapeutics. May, 2005 | Pubmed ID: 15897234 Prediction of Myelotoxicity Based on Bone Marrow Radiation-absorbed Dose: Radioimmunotherapy Studies Using 90Y- and 177Lu-labeled J591 Antibodies Specific for Prostate-specific Membrane Antigen Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. May, 2005 | Pubmed ID: 15872360 Phase I Trial of 177lutetium-labeled J591, a Monoclonal Antibody to Prostate-specific Membrane Antigen, in Patients with Androgen-independent Prostate Cancer Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jul, 2005 | Pubmed ID: 15837970 Pharmacokinetics and Biodistribution of 111In- and 177Lu-labeled J591 Antibody Specific for Prostate-specific Membrane Antigen: Prediction of 90Y-J591 Radiation Dosimetry Based on 111In or 177Lu? Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Apr, 2005 | Pubmed ID: 15809486 Synthesis and in Vitro Testing of J591 Antibody-dendrimer Conjugates for Targeted Prostate Cancer Therapy Bioconjugate Chemistry. Nov-Dec, 2004 | Pubmed ID: 15546182 Phase I Trial of Yttrium-90-labeled Anti-prostate-specific Membrane Antigen Monoclonal Antibody J591 for Androgen-independent Prostate Cancer Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jul, 2004 | Pubmed ID: 15173215 Radioimmunotherapy of Prostate Cancer in Human Xenografts Using Monoclonal Antibodies Specific to Prostate Specific Membrane Antigen (PSMA): Studies in Nude Mice The Prostate. Feb, 2004 | Pubmed ID: 14716739 Clinical Use of Monoclonal Antibody HuJ591 Therapy: Targeting Prostate Specific Membrane Antigen The Journal of Urology. Dec, 2003 | Pubmed ID: 14610416 Targeted Systemic Therapy of Prostate Cancer with a Monoclonal Antibody to Prostate-specific Membrane Antigen Seminars in Oncology. Oct, 2003 | Pubmed ID: 14571414 Targeting Metastatic Prostate Cancer with Radiolabeled Monoclonal Antibody J591 to the Extracellular Domain of Prostate Specific Membrane Antigen The Journal of Urology. Nov, 2003 | Pubmed ID: 14532761 A Novel Cytoplasmic Tail MXXXL Motif Mediates the Internalization of Prostate-specific Membrane Antigen Molecular Biology of the Cell. Dec, 2003 | Pubmed ID: 14528023 Prostate-specific Membrane Antigen Association with Filamin A Modulates Its Internalization and NAALADase Activity Cancer Research. May, 2003 | Pubmed ID: 12750292 Radiolabeled Monoclonal Antibodies Specific to the Extracellular Domain of Prostate-specific Membrane Antigen: Preclinical Studies in Nude Mice Bearing LNCaP Human Prostate Tumor Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Apr, 2003 | Pubmed ID: 12679407 前立腺特定膜抗原, 前立腺幹細胞抗原と前立腺特異抗原前立腺組織と培養上皮細胞の極性。 The Prostate. Apr, 2003 | Pubmed ID: 12640656 患者とヒト内皮細胞に由来する前立腺循環腫瘍細胞との間のE-セレクチン介在性の相互作用を観察するin vitro法での Gunjan Gakhar1, Neil H. Bander2, David M. Nanus1 1Department of Medicine, Weill Cornell Medical College, 2Department of Urology, Weill Cornell Medical College JoVE 51468 Medicine
患者とヒト内皮細胞に由来する前立腺循環腫瘍細胞との間のE-セレクチン介在性の相互作用を観察するin vitro法での Gunjan Gakhar1, Neil H. Bander2, David M. Nanus1 1Department of Medicine, Weill Cornell Medical College, 2Department of Urology, Weill Cornell Medical College JoVE 51468 Medicine